1887

oa Current Allergy & Clinical Immunology - Singulair 4 mg - : product news

Volume 23, Issue 3
  • ISSN : 1609-3607

 

Abstract

MSD (Pty) Ltd is proud to announce the introduction of SINGULAIR 4 mg. Studies have shown that asthma in children under the age of six is on the increase worldwide. SINGULAIR 4 mg is the first asthma controller therapy, that is not a steroid, to be approved in South Africa for children as young as 2 years old.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/caci/23/3/EJC21663
2010-08-01
2019-10-20

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error